NUX Male Enhancement capsule, 1-count blister card, distributed by SX Power CO., Chicago, Il 6061...
FDA Drug Recall #D-0572-2023 — Class I — April 26, 2023
Recall Summary
| Recall Number | D-0572-2023 |
| Classification | Class I — Serious risk |
| Date Initiated | April 26, 2023 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Gadget Island, Inc |
| Location | West Sacramento, CA |
| Product Type | Drugs |
| Quantity | 18 blister cards |
Product Description
NUX Male Enhancement capsule, 1-count blister card, distributed by SX Power CO., Chicago, Il 60612, UPC 6 01577 51236 3.
Reason for Recall
Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Distribution Pattern
Nationwide in the USA.
Lot / Code Information
Lot#: RO 927996, Exp: 12/25/2024
Other Recalls from Gadget Island, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0573-2023 | Class I | DYNAMITE SUPER capsule, 58,000 MG, 1-count blis... | Apr 26, 2023 |
| D-0571-2023 | Class I | Pro Power Knight Plus capsule, 2550mg, 1-count ... | Apr 26, 2023 |
| D-0106-2018 | Class I | grande X 5800 capsule, (Maca Root 120 mg, Horny... | Sep 15, 2017 |
| D-0105-2018 | Class I | FIFTY SHADES 6000 capsule, Proprietary Raw Mate... | Sep 15, 2017 |
| D-0104-2018 | Class I | PapaZen 3300 capsule, Proprietary Blend 1800mg,... | Sep 15, 2017 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.